BEYOND MEAT INC (BYND)

US08862E1091 - Common Stock

3.91  -0.1 (-2.49%)

After market: 3.92 +0.01 (+0.26%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BYND. BYND was compared to 89 industry peers in the Food Products industry. Both the profitability and financial health of BYND have multiple concerns. While showing a medium growth rate, BYND is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year BYND has reported negative net income.
BYND had a negative operating cash flow in the past year.
In the past 5 years BYND always reported negative net income.
BYND had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -39.04%, BYND is doing worse than 85.54% of the companies in the same industry.
Industry RankSector Rank
ROA -39.04%
ROE N/A
ROIC N/A
ROA(3y)-30.44%
ROA(5y)-21.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for BYND so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

3

2. Health

2.1 Basic Checks

BYND does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BYND has more shares outstanding
The number of shares outstanding for BYND has been increased compared to 5 years ago.
The debt/assets ratio for BYND is higher compared to a year ago.

2.2 Solvency

BYND has an Altman-Z score of -2.79. This is a bad value and indicates that BYND is not financially healthy and even has some risk of bankruptcy.
BYND has a worse Altman-Z score (-2.79) than 85.54% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -2.79
ROIC/WACCN/A
WACC5.91%

2.3 Liquidity

A Current Ratio of 3.43 indicates that BYND has no problem at all paying its short term obligations.
With an excellent Current ratio value of 3.43, BYND belongs to the best of the industry, outperforming 86.75% of the companies in the same industry.
BYND has a Quick Ratio of 1.99. This is a normal value and indicates that BYND is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.99, BYND belongs to the best of the industry, outperforming 84.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.43
Quick Ratio 1.99

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 33.68% over the past year.
The Revenue has decreased by -7.45% in the past year.
BYND shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.33% yearly.
EPS 1Y (TTM)33.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.39%
Revenue 1Y (TTM)-7.45%
Revenue growth 3Y-5.49%
Revenue growth 5Y31.33%
Sales Q2Q%7.56%

3.2 Future

The Earnings Per Share is expected to grow by 11.78% on average over the next years. This is quite good.
BYND is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.14% yearly.
EPS Next Y43.14%
EPS Next 2Y25.83%
EPS Next 3Y17.78%
EPS Next 5Y11.78%
Revenue Next Year-3.15%
Revenue Next 2Y0.43%
Revenue Next 3Y2.19%
Revenue Next 5Y2.14%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

0

4. Valuation

4.1 Price/Earnings Ratio

BYND reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BYND is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

BYND's earnings are expected to grow with 17.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y25.83%
EPS Next 3Y17.78%

0

5. Dividend

5.1 Amount

No dividends for BYND!.
Industry RankSector Rank
Dividend Yield N/A

BEYOND MEAT INC

NASDAQ:BYND (1/6/2025, 4:48:24 PM)

After market: 3.92 +0.01 (+0.26%)

3.91

-0.1 (-2.49%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)02-11 2025-02-11/amc
Inst Owners43.98%
Inst Owner Change0%
Ins Owners4.7%
Ins Owner Change10.74%
Market Cap254.93M
Analysts48.24
Price Target5.68 (45.27%)
Short Float %44.45%
Short Ratio7.7
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.41%
Min EPS beat(2)-2.64%
Max EPS beat(2)9.47%
EPS beat(4)1
Avg EPS beat(4)-0.28%
Min EPS beat(4)-5.56%
Max EPS beat(4)9.47%
EPS beat(8)4
Avg EPS beat(8)0.98%
EPS beat(12)4
Avg EPS beat(12)-15.8%
EPS beat(16)4
Avg EPS beat(16)-38.33%
Revenue beat(2)1
Avg Revenue beat(2)1.22%
Min Revenue beat(2)-1.6%
Max Revenue beat(2)4.04%
Revenue beat(4)2
Avg Revenue beat(4)2.33%
Min Revenue beat(4)-1.6%
Max Revenue beat(4)8.37%
Revenue beat(8)3
Avg Revenue beat(8)-1.09%
Revenue beat(12)3
Avg Revenue beat(12)-3.05%
Revenue beat(16)4
Avg Revenue beat(16)-2.93%
PT rev (1m)2.63%
PT rev (3m)0.16%
EPS NQ rev (1m)0%
EPS NQ rev (3m)9.65%
EPS NY rev (1m)-1.75%
EPS NY rev (3m)1.44%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.1%
Revenue NY rev (1m)-0.01%
Revenue NY rev (3m)-0.86%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.79
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.58
EYN/A
EPS(NY)-1.57
Fwd EYN/A
FCF(TTM)-1.61
FCFYN/A
OCF(TTM)-1.51
OCFYN/A
SpS4.96
BVpS-9.39
TBVpS-9.39
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -39.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.44%
ROA(5y)-21.07%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 13.66%
Cap/Sales 2.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.43
Quick Ratio 1.99
Altman-Z -2.79
F-Score2
WACC5.91%
ROIC/WACCN/A
Cap/Depr(3y)291.55%
Cap/Depr(5y)352.34%
Cap/Sales(3y)16.61%
Cap/Sales(5y)15.42%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.39%
EPS Next Y43.14%
EPS Next 2Y25.83%
EPS Next 3Y17.78%
EPS Next 5Y11.78%
Revenue 1Y (TTM)-7.45%
Revenue growth 3Y-5.49%
Revenue growth 5Y31.33%
Sales Q2Q%7.56%
Revenue Next Year-3.15%
Revenue Next 2Y0.43%
Revenue Next 3Y2.19%
Revenue Next 5Y2.14%
EBIT growth 1Y-14.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60.38%
EBIT Next 3Y20.83%
EBIT Next 5Y13.74%
FCF growth 1Y77.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.15%
OCF growth 3YN/A
OCF growth 5YN/A